Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New study will assess safety of Maxamine-containing triple drug therapy in HCV

April 3, 2000

New series of gastric acid pump inhibitors in early research at AstraZeneca

April 3, 2000

Recent Japanese patent covers Arax's new antiulcer agents

March 31, 2000

Salix receives FDA approvable letter for balsalazide disodium

March 29, 2000

Cangene begins pivotal HBV study, terminates agreement with Octapharma

March 29, 2000

Novel gastric antisecretory agents designed by AstraZeneca scientists

March 29, 2000

Positive preliminary results reported for Enzo's phase I trial of EHT-899

March 29, 2000

Carrington Laboratories discontinues development of Aliminase due to disappointing phase III results

March 29, 2000

Extensive review of novel cytoprotectant appears in supplementary issue of DOT

March 29, 2000

Janssen to cease cisapride marketing in the U.S.

March 28, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...